title: Outcomes and complications of pneumatic retinopexy over a 12-year period.
abstract: OBJECTIVE
  To evaluate anatomic and clinical outcomes of pneumatic retinopexy for treatment of primary retinal detachment.
  
  
  METHODS
  Noncomparative, single-center, consecutive, interventional case series evaluating all patients treated between 2000 and 2012. Patients with less than 1 month of follow-up or coexisting neovascular age-related macular degeneration, uveitis, endophthalmitis, or prior posterior segment surgery were excluded.
  
  
  RESULTS
  Sixty-three eyes of 63 patients with primary retinal detachment treated with pneumatic retinopexy were included. Median follow-up was 10.3 months. Single-operation success (SOS), defined as anatomic reattachment with pneumatic retinopexy alone, occurred in 40 eyes (63%). The retina was successfully reattached in 21 of the other 23 eyes (91%) with one additional surgery. There was no difference in visual acuity outcomes between SOS and additional surgical intervention (P = .85). New or missed breaks were identified in 19 of 63 eyes (30%). Postoperative subretinal fluid was observed in 22 of 63 eyes (35%) and persisted at last follow-up in two of 63 eyes (3%). At final follow-up, the retina was fully attached in 97% of eyes.
  
  
  CONCLUSIONS
  Pneumatic retinopexy remains a reasonably successful option in the management of primary retinal detachment. No difference in best corrected visual acuity outcomes in eyes achieving SOS versus those requiring additional surgery was demonstrated.
authors.forename: Yasha S
authors.initials: YS
authors.lastname: Modi
authors.forename: Aliza
authors.initials: A
authors.lastname: Epstein
authors.forename: Harry W
authors.initials: HW
authors.lastname: Flynn
authors.forename: Wei
authors.initials: W
authors.lastname: Shi
authors.forename: William E
authors.initials: WE
authors.lastname: Smiddy
mesh_terms: D003452:Cryosurgery / Q000009:adverse effects*; D058450:Endotamponade; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D007431:Intraoperative Complications; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012163:Retinal Detachment / Q000503:physiopathology / Q000601:surgery*; D012167:Retinal Perforations / Q000503:physiopathology / Q000601:surgery*; D012189:Retrospective Studies; D058471:Subretinal Fluid; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology
chemical_list: D005466:Fluorocarbons; C042852:perflutren; D013459:Sulfur Hexafluoride